[Late hematologic status after chemotherapy observed in patients 3 to 10 years after treatment].
The aim of the present study is the evaluation of late hematological complication in patients who received aggressive chemotherapy, and were observed 3, 5 and 10 years after treatment was completed. In the group of 35 patients, besides high percent of early hematological complications, there was only one case of anemia grade 2 (acc. to WHO score). We concluded that the hematological recovery after aggressive chemotherapy was satisfactory. No secondary hematological malignancies have been found.
Pawlicki
M
M
Kliniki Chemioterapii Centrum Onkologii im. M. Skłodowskiej-Curie, Oddział w Krakowie.
Zuchowska-Vogelgesang
B
B
Ziobro
M
M
Rolski
J
J
Koralewski
P
P
Mirek
T
T
Pernal
J
J
Zemełka
T
T
D000328:Adult; D000368:Aged; D000740:Anemia / Q000139:chemically induced; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D005260:Female; D005500:Follow-Up Studies; D006402:Hematologic Diseases / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy
D000970:Antineoplastic Agents
Późne powikłania hematologiczne po leczeniu chemicznym obserwowane u pacjentów w 3 do 10 lat po leczeniu.